# Left Atrium Reservoir Function Modulation in Patients With Atrial Fibrillation: Digoxin Versus Beta Blocker

> **NCT05540600** · PHASE3 · UNKNOWN · sponsor: **University of Monastir** · enrollment: 30 (estimated)

## Conditions studied

- Atrial Fibrillation
- Left Atrial Rhythm

## Interventions

- **DRUG:** Digoxin 0.25 mg
- **DRUG:** Bisoprolol

## Key facts

- **NCT ID:** NCT05540600
- **Lead sponsor:** University of Monastir
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-09-12
- **Primary completion:** 2023-01-01
- **Final completion:** 2023-12-01
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2022-09-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05540600

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05540600, "Left Atrium Reservoir Function Modulation in Patients With Atrial Fibrillation: Digoxin Versus Beta Blocker". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT05540600. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*